rs12327948

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001111067.4(ACVR1):​c.-8+5480C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.681 in 152,016 control chromosomes in the GnomAD database, including 39,966 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.68 ( 39966 hom., cov: 32)

Consequence

ACVR1
NM_001111067.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.136

Publications

2 publications found
Variant links:
Genes affected
ACVR1 (HGNC:171): (activin A receptor type 1) Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I ( I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. This gene encodes activin A type I receptor which signals a particular transcriptional response in concert with activin type II receptors. Mutations in this gene are associated with fibrodysplasia ossificans progressive. [provided by RefSeq, Jul 2008]
ACVR1 Gene-Disease associations (from GenCC):
  • fibrodysplasia ossificans progressiva
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, ClinGen, Orphanet
  • congenital heart disease
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.837 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001111067.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACVR1
NM_001111067.4
MANE Select
c.-8+5480C>G
intron
N/ANP_001104537.1
ACVR1
NM_001105.5
c.-8+5480C>G
intron
N/ANP_001096.1
ACVR1
NM_001347663.1
c.-8+5480C>G
intron
N/ANP_001334592.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACVR1
ENST00000434821.7
TSL:1 MANE Select
c.-8+5480C>G
intron
N/AENSP00000405004.1
ACVR1
ENST00000263640.7
TSL:1
c.-8+5480C>G
intron
N/AENSP00000263640.3
ACVR1
ENST00000410057.6
TSL:1
c.-8+5480C>G
intron
N/AENSP00000387127.2

Frequencies

GnomAD3 genomes
AF:
0.682
AC:
103541
AN:
151898
Hom.:
39958
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.281
Gnomad AMI
AF:
0.797
Gnomad AMR
AF:
0.804
Gnomad ASJ
AF:
0.873
Gnomad EAS
AF:
0.795
Gnomad SAS
AF:
0.859
Gnomad FIN
AF:
0.841
Gnomad MID
AF:
0.810
Gnomad NFE
AF:
0.838
Gnomad OTH
AF:
0.724
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.681
AC:
103573
AN:
152016
Hom.:
39966
Cov.:
32
AF XY:
0.687
AC XY:
51009
AN XY:
74288
show subpopulations
African (AFR)
AF:
0.281
AC:
11651
AN:
41426
American (AMR)
AF:
0.804
AC:
12271
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.873
AC:
3029
AN:
3470
East Asian (EAS)
AF:
0.795
AC:
4119
AN:
5180
South Asian (SAS)
AF:
0.859
AC:
4142
AN:
4820
European-Finnish (FIN)
AF:
0.841
AC:
8875
AN:
10558
Middle Eastern (MID)
AF:
0.820
AC:
241
AN:
294
European-Non Finnish (NFE)
AF:
0.838
AC:
56990
AN:
67980
Other (OTH)
AF:
0.725
AC:
1528
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1229
2458
3688
4917
6146
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
780
1560
2340
3120
3900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.746
Hom.:
5665
Bravo
AF:
0.655
Asia WGS
AF:
0.785
AC:
2722
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
3.3
DANN
Benign
0.39
PhyloP100
0.14
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12327948; hg19: chr2-158669417; API